Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 0TJ631J0KP

Structure

InChI Key VGEXRDWWPSGZDH-UHFFFAOYSA-N
Smile CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1
InChI
InChI=1S/C35H34ClN7O3S2/c1-35(2,3)30-19-32(43(41-30)23-12-14-27(45)26(36)18-23)38-34(46)37-20-22-8-4-6-10-28(22)48-24-13-15-31-39-40-33(42(31)21-24)25-9-5-7-11-29(25)47-17-16-44/h4-15,18-19,21,44-45H,16-17,20H2,1-3H3,(H2,37,38,46)

Physicochemical Descriptors

Property Name Value
Molecular Formula C35H34ClN7O3S2
Molecular Weight 700.29
AlogP 7.8
Hydrogen Bond Acceptor 10.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 10.0
Polar Surface Area 129.6
Molecular species NEUTRAL
Aromatic Rings 6.0
Heavy Atoms 48.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR MAP kinase p38 alpha inhibitor PubMed Other
Primary Target
mitogen-activated protein kinase 14

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Asthma 2 D001249 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1056164-52-3
ChEMBL CHEMBL1938400
DrugBank DB12138
EPA CompTox DTXSID70147214
FDA SRS 0TJ631J0KP
Guide to Pharmacology 8179
PDB YIS
PubChem 11714580
SureChEMBL SCHEMBL981777